Explore
Trendline
Genentech Restructures R, Leading to Executive Departures and Unit Closures
Genentech Restructures R, Leading to Executive Departures and Unit Closures
Read More
Trendline
Genentech Restructures R, Leading to Executive Departures and Layoffs
Genentech Restructures R, Leading to Executive Departures and Layoffs
Read More
Trendline
EVERSANA Appoints Jen Norton as Market Access Leader to Enhance Pricing and Access Strategies
EVERSANA Appoints Jen Norton as Market Access Leader to Enhance Pricing and Access Strategies
Read More
Trendline
EVERSANA Appoints Jen Norton to Lead Market Access Division Amid Complex Pricing Landscape
EVERSANA Appoints Jen Norton to Lead Market Access Division Amid Complex Pricing Landscape
Read More
Trendline
EVERSANA Appoints Jen Norton as Market Access Leader to Navigate Complex Pricing Landscape
EVERSANA Appoints Jen Norton as Market Access Leader to Navigate Complex Pricing Landscape
Read More
Trendline
Rising Demand for GLP-1s Poses Challenges and Opportunities for Healthcare Costs
Rising Demand for GLP-1s Poses Challenges and Opportunities for Healthcare Costs
Read More
Trendline
PCMA Introduces New Policy Platform to Address Drug Affordability Challenges
PCMA Introduces New Policy Platform to Address Drug Affordability Challenges
Read More
Trendline
Drugmakers Shift Focus to Monthly Weight Loss Injections for Enhanced Convenience
Drugmakers Shift Focus to Monthly Weight Loss Injections for Enhanced Convenience
Read More
Trendline
Biopharma Industry Prepares for Growth with Talent Strategies Webinar
Biopharma Industry Prepares for Growth with Talent Strategies Webinar
Read More
Trendline
Life Science Trade Groups Urged to Support Industry Amid Federal Funding Uncertainty
Life Science Trade Groups Urged to Support Industry Amid Federal Funding Uncertainty
Read More
Trendline
FDA Approves New Maintenance Regimen for Eli Lilly's Eczema Drug Ebglyss, Offering Fewer Injections
FDA Approves New Maintenance Regimen for Eli Lilly's Eczema Drug Ebglyss, Offering Fewer Injections
Read More
Trendline
Eli Lilly Gains FDA Approval for Ebglyss Eczema Drug with New Maintenance Dosing
Eli Lilly Gains FDA Approval for Ebglyss Eczema Drug with New Maintenance Dosing
Read More